Fresh Issue of 165crs (50 for capex | 48 for Working capital | 20 for debt payment) + OFS of 237crs (Partially by promoter & PE Tano selling out as the fund tenure is up)
~ Total raise of 402crs
2/ About the company (Not a Biotech company)
A Contract manufacturer for formulation cos. (204 in total) for Indian markets & a small domestic OTC biz
3279 products, 4 plants with 700cr tablets/capsules capacity
Emphasis on chronic (60% of rev) & complex generics (70% of rev)
Developer & manufacturer of high value, non- commoditized APIs (complex & low competition) in chronic therapeutic areas: CVS, CNS, pain management & diabetes, etc
Basic details about the IPO 👇
Note: After paying off liabilities, 150crs remain for capex.
2/ The Journey
Established the API business in FY02
Since 2015, Have not received any adverse reactions from regulators (USFDA, PMDA) in the total 38 audits & inspections & Have gone through 432 customer audits.
Filled 403 DMFs & CEP registration across markets globally.
A thread on the snippets (paragraphs & quotes) from the book ‘The Hidden Life Of Trees: What They Feel, How They Communicate’ by Peter Wolleben (A forester 🌳)
‘Trees in the forest are social beings.’
This thread will be updated as I read further & further.
Why your nearby restaurant has a sweet-sour relationship with Zomato/Swiggy?
A mini Thread 🧵👇
1/ Aggregator Economics
Aggregators are cash-guzzling businesses
Although the restaurant volumes go up, increasingly these companies are getting stricter with respect to their cash flows leaving no cut for the restaurant owners
With the listing, this will continue to grow.
2/ Customer Data Masking
Aggregators don't share any user data with the owners leaving them clueless about their customer base, their demographics & trends.
Owners feel that they are losing their brand value & their food is getting commoditized.